• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症首次发病后患者如何进入医疗保健系统?环境和医生专业对诊断速度的影响。

How do patients enter the healthcare system after the first onset of multiple sclerosis symptoms? The influence of setting and physician specialty on speed of diagnosis.

机构信息

Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.

Department of Neurology, University Hospital Bern and University of Bern, Bern, Switzerland/Neurology and Neurorehabilitation Centre, Lucerne Cantonal Hospital, Lucerne, Switzerland.

出版信息

Mult Scler. 2020 Apr;26(4):489-500. doi: 10.1177/1352458518823955. Epub 2019 Jan 18.

DOI:10.1177/1352458518823955
PMID:31456464
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7140343/
Abstract

BACKGROUND

Diagnosing multiple sclerosis (MS) early is crucial to avoid future disability. However, potentially preventable delays in the diagnostic cascade from contact with a physician to definite diagnosis still occur and their causes are still unclear.

OBJECTIVE

To identify the possible causes of delays in the diagnostic process.

METHODS

We analyzed the data of the Swiss MS Registry. With logistic regression, we modeled the time from the first contact to the first consultation (contact-to-evaluation time, ⩽1 month/>1 month) and the evaluation-to-diagnosis time (⩽6 months/>6 months). Potential factors were health system characteristics, sociodemographic variables, first symptoms, and MS type.

RESULTS

We included 522 participants. Mostly, general practitioners (67%) were contacted first, without delaying the diagnosis. In contrast, first symptoms and MS type were the major contributors to delays: gait problems were associated with longer contact-to-evaluation times, depression as a concomitant symptom with longer evaluation-to-diagnosis times, and having primary progressive MS prolonged both phases. In addition, living in mountainous areas was associated with longer contact-to-evaluation times, whereas diagnosis after 2000 was associated with faster diagnoses.

CONCLUSION

For a quicker diagnosis, awareness of MS as a differential diagnosis of gait disorders and the co-occurrence of depression at onset should be raised, and these symptoms should be attentively followed.

摘要

背景

早期诊断多发性硬化症(MS)对于避免未来残疾至关重要。然而,从与医生接触到明确诊断的诊断过程中仍存在潜在可预防的延迟,其原因仍不清楚。

目的

确定诊断过程中延迟的可能原因。

方法

我们分析了瑞士 MS 登记处的数据。通过逻辑回归,我们构建了从首次接触到首次就诊(接触-评估时间,≤1 个月/>1 个月)和评估-诊断时间(≤6 个月/>6 个月)的时间模型。潜在因素包括卫生系统特征、社会人口统计学变量、首发症状和 MS 类型。

结果

我们纳入了 522 名参与者。大多数情况下,首先联系的是全科医生(67%),并没有延迟诊断。相比之下,首发症状和 MS 类型是导致延迟的主要因素:步态问题与接触-评估时间延长有关,抑郁作为伴随症状与评估-诊断时间延长有关,原发性进展型 MS 则延长了两个阶段。此外,居住在山区与接触-评估时间延长有关,而 2000 年后的诊断与更快的诊断有关。

结论

为了更快地诊断,应提高对 MS 作为步态障碍鉴别诊断的认识,并注意首发时的抑郁症状,以便及时进行诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66fb/7140343/dfe5297d4fcf/10.1177_1352458518823955-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66fb/7140343/0ba489a8e889/10.1177_1352458518823955-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66fb/7140343/d9cb98bfd2ca/10.1177_1352458518823955-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66fb/7140343/000125b12de0/10.1177_1352458518823955-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66fb/7140343/dfe5297d4fcf/10.1177_1352458518823955-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66fb/7140343/0ba489a8e889/10.1177_1352458518823955-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66fb/7140343/d9cb98bfd2ca/10.1177_1352458518823955-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66fb/7140343/000125b12de0/10.1177_1352458518823955-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66fb/7140343/dfe5297d4fcf/10.1177_1352458518823955-fig4.jpg

相似文献

1
How do patients enter the healthcare system after the first onset of multiple sclerosis symptoms? The influence of setting and physician specialty on speed of diagnosis.多发性硬化症首次发病后患者如何进入医疗保健系统?环境和医生专业对诊断速度的影响。
Mult Scler. 2020 Apr;26(4):489-500. doi: 10.1177/1352458518823955. Epub 2019 Jan 18.
2
Factors associated with perceived need for mental health care in multiple sclerosis.多发性硬化症患者感知心理健康需求的相关因素。
Mult Scler Relat Disord. 2018 Oct;25:179-185. doi: 10.1016/j.msard.2018.07.043. Epub 2018 Jul 29.
3
Factors influencing patient satisfaction with the first diagnostic consultation in multiple sclerosis: a Swiss Multiple Sclerosis Registry (SMSR) study.影响多发性硬化症患者首次诊断咨询满意度的因素:瑞士多发性硬化症登记研究(SMSR)
J Neurol. 2020 Jan;267(1):153-161. doi: 10.1007/s00415-019-09563-y. Epub 2019 Oct 8.
4
Diagnostic Delay of Multiple Sclerosis in a Portuguese Population.葡萄牙人群中多发性硬化症的诊断延迟
Acta Med Port. 2019 Apr 30;32(4):289-294. doi: 10.20344/amp.11187.
5
Delayed diagnosis of multiple sclerosis in a low prevalence country.多发性硬化症在低流行国家的延迟诊断。
Neurol Res. 2021 Jul;43(7):521-527. doi: 10.1080/01616412.2020.1866374. Epub 2020 Dec 23.
6
Familial multiple sclerosis patients have a shorter delay in diagnosis than sporadic cases.家族性多发性硬化症患者的诊断延迟时间短于散发性病例。
Mult Scler Relat Disord. 2019 Jul;32:97-102. doi: 10.1016/j.msard.2019.04.012. Epub 2019 Apr 13.
7
[Multiple sclerosis, from the first signs to the diagnostic consultation].[多发性硬化症,从首发症状到诊断咨询]
Soins. 2009 Nov(740):36-8.
8
Characteristics of multiple sclerosis at onset and delay of diagnosis and treatment in Spain (the Novo Study).西班牙多发性硬化症的发病特征及诊治延迟情况(Novo 研究)。
J Neurol. 2010 Sep;257(9):1500-7. doi: 10.1007/s00415-010-5560-1. Epub 2010 Apr 10.
9
Factors associated with delay to medical recognition in two Canadian multiple sclerosis cohorts.与加拿大两个多发性硬化症队列中医疗识别延迟相关的因素。
J Neurol Sci. 2010 May 15;292(1-2):57-62. doi: 10.1016/j.jns.2010.02.007. Epub 2010 Mar 4.
10
The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.在全科医疗中,直接转诊进行快速CT扫描对早期肺癌检测的效果。一项临床、整群随机试验。
Dan Med J. 2015 Mar;62(3).

引用本文的文献

1
Diagnostic delay and misdiagnosis of symptoms reported by patients with multiple sclerosis participating in a research registry.参与一项研究登记的多发性硬化症患者报告症状的诊断延迟和误诊情况。
Mult Scler J Exp Transl Clin. 2025 Apr 17;11(2):20552173251333390. doi: 10.1177/20552173251333390. eCollection 2025 Apr-Jun.
2
Diagnostic inequalities relating to physical healthcare among people with mental health conditions: a systematic review.心理健康状况患者在身体保健方面的诊断不平等:一项系统综述。
EClinicalMedicine. 2025 Jan 10;80:103026. doi: 10.1016/j.eclinm.2024.103026. eCollection 2025 Feb.
3
Delays in Multiple Sclerosis diagnosis (DIMES): protocol for a multicentre, observational study of multiple sclerosis diagnostic pathways in the United Kingdom and Republic of Ireland.

本文引用的文献

1
Factors associated with time from first-symptoms to diagnosis and treatment initiation of Multiple Sclerosis in Switzerland.瑞士多发性硬化症从首次出现症状到诊断及开始治疗的时间相关因素。
Mult Scler J Exp Transl Clin. 2018 Dec 6;4(4):2055217318814562. doi: 10.1177/2055217318814562. eCollection 2018 Oct-Dec.
2
Patterns of care for Multiple Sclerosis in a setting of universal care access: A cross-sectional study.在普遍获得医疗保健的环境中多发性硬化症的护理模式:一项横断面研究。
Mult Scler Relat Disord. 2019 Feb;28:17-25. doi: 10.1016/j.msard.2018.11.033. Epub 2018 Dec 2.
3
The Swiss Multiple Sclerosis Registry (SMSR): study protocol of a participatory, nationwide registry to promote epidemiological and patient-centered MS research.
多发性硬化症诊断延误(DIMES)研究方案:一项在英国和爱尔兰开展的多发性硬化症诊断途径的多中心观察性研究
BMC Neurol. 2024 Mar 28;24(1):105. doi: 10.1186/s12883-024-03598-z.
4
Factors associated with depressive mood at the onset of multiple sclerosis - an analysis of 781 patients of the German NationMS cohort.多发性硬化症发病时与抑郁情绪相关的因素——对德国全国多发性硬化症队列781例患者的分析
Ther Adv Neurol Disord. 2023 Sep 8;16:17562864231197309. doi: 10.1177/17562864231197309. eCollection 2023.
5
Global Barriers to the Diagnosis of Multiple Sclerosis: Data From the Multiple Sclerosis International Federation Atlas of MS, Third Edition.全球多发性硬化症诊断障碍:多发性硬化症国际联合会 MS 图谱,第三版的数据。
Neurology. 2023 Aug 8;101(6):e624-e635. doi: 10.1212/WNL.0000000000207481. Epub 2023 Jun 15.
6
The Multiple Sclerosis Prodrome: Evidence to Action.多发性硬化前驱期:从证据到行动。
Front Neurol. 2022 Jan 31;12:761408. doi: 10.3389/fneur.2021.761408. eCollection 2021.
7
Onset Symptom Clusters in Multiple Sclerosis: Characteristics, Comorbidities, and Risk Factors.多发性硬化症的起病症状群:特征、合并症及危险因素
Front Neurol. 2021 Jul 6;12:693440. doi: 10.3389/fneur.2021.693440. eCollection 2021.
8
Factors influencing patient satisfaction with the first diagnostic consultation in multiple sclerosis: a Swiss Multiple Sclerosis Registry (SMSR) study.影响多发性硬化症患者首次诊断咨询满意度的因素:瑞士多发性硬化症登记研究(SMSR)
J Neurol. 2020 Jan;267(1):153-161. doi: 10.1007/s00415-019-09563-y. Epub 2019 Oct 8.
9
Illuminating an Invisible Epidemic: A Systemic Review of the Clinical and Economic Benefits of Early Diagnosis and Treatment in Inflammatory Disease and Related Syndromes.揭示一种隐形流行病:炎症性疾病及相关综合征早期诊断与治疗的临床及经济效益系统评价
J Clin Med. 2019 Apr 11;8(4):493. doi: 10.3390/jcm8040493.
瑞士多发性硬化症登记处(SMSR):一项参与性全国登记处的研究方案,以促进基于流行病学和以患者为中心的多发性硬化症研究。
BMC Neurol. 2018 Aug 13;18(1):111. doi: 10.1186/s12883-018-1118-0.
4
The disease burden of Multiple Sclerosis from the individual and population perspective: Which symptoms matter most?从个体和人群角度看多发性硬化症的疾病负担:哪些症状最重要?
Mult Scler Relat Disord. 2018 Oct;25:112-121. doi: 10.1016/j.msard.2018.07.013. Epub 2018 Jul 21.
5
Early versus later treatment start in multiple sclerosis: a register-based cohort study.早期与晚期多发性硬化症治疗开始时间:基于登记的队列研究。
Eur J Neurol. 2018 Oct;25(10):1262-e110. doi: 10.1111/ene.13692. Epub 2018 Jul 9.
6
A digitally facilitated citizen-science driven approach accelerates participant recruitment and increases study population diversity.一种由数字技术推动、公民科学驱动的方法加快了参与者招募速度,并增加了研究人群的多样性。
Swiss Med Wkly. 2018 May 16;148:w14623. doi: 10.4414/smw.2018.14623. eCollection 2018.
7
Comparative analysis of natalizumab versus fingolimod as second-line treatment in relapsing-remitting multiple sclerosis.比较那他珠单抗与芬戈莫德作为复发缓解型多发性硬化二线治疗的疗效分析。
Mult Scler. 2018 May;24(6):777-785. doi: 10.1177/1352458518768433. Epub 2018 Apr 24.
8
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.多发性硬化症的诊断:2017 年麦当劳标准修订版。
Lancet Neurol. 2018 Feb;17(2):162-173. doi: 10.1016/S1474-4422(17)30470-2. Epub 2017 Dec 21.
9
Older Americans Were Sicker And Faced More Financial Barriers To Health Care Than Counterparts In Other Countries.美国老年人的健康状况更差,面临着比其他国家同龄人更多的医疗保健财务障碍。
Health Aff (Millwood). 2017 Dec;36(12):2123-2132. doi: 10.1377/hlthaff.2017.1048. Epub 2017 Nov 15.
10
New insights into the burden and costs of multiple sclerosis in Europe: Results for Switzerland.欧洲多发性硬化症负担和成本的新见解:瑞士的结果。
Mult Scler. 2017 Aug;23(2_suppl):192-203. doi: 10.1177/1352458517708685.